Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-01-23

Clinical Trial Update: Biomarker Analysis for GBA Associated Parkinson's Disease

View source ↗

Summary

This clinical trial update describes biomarker analysis for Gaucher disease–associated Parkinson's disease (GBA-related). The current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Lysosomal and Rare Disorders Research and Treatment Center, Inc. | Conditions: Parkinson Disease, Gaucher Disease | Status: UNKNOWN